Lixte Biotechnology Holdings, Inc. (LIXT)

NASDAQ: LIXT · Real-Time Price · USD

1.240

0.00 (0.00%)

Apr 21, 2025, 4:00 PM EDT - Market closed

LIXT Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Selling, General & Admin	2.85	4.19	4.96	4.98	2.04	Upgrade
Research & Development	0.73	0.9	1.35	1.74	1.22	Upgrade
Operating Expenses	3.57	5.09	6.31	6.72	3.27	Upgrade
Operating Income	-3.57	-5.09	-6.31	-6.72	-3.27	Upgrade
Interest Expense	-0.02	-0.02	-0.01	-0.01	-0	Upgrade
Interest & Investment Income	0.01	0.02	0.01	0	0	Upgrade
Currency Exchange Gain (Loss)	-0	0	-0	-0	0	Upgrade
EBT Excluding Unusual Items	-3.59	-5.09	-6.31	-6.73	-3.26	Upgrade
Pretax Income	-3.59	-5.09	-6.31	-6.73	-3.26	Upgrade
Net Income	-3.59	-5.09	-6.31	-6.73	-3.26	Upgrade
Net Income to Common	-3.59	-5.09	-6.31	-6.73	-3.26	Upgrade
Shares Outstanding (Basic)	2	2	2	1	1	Upgrade
Shares Outstanding (Diluted)	2	2	2	1	1	Upgrade
Shares Change (YoY)	17.41%	21.10%	17.41%	19.48%	0.92%	Upgrade
EPS (Basic)	-1.59	-2.66	-3.99	-4.99	-2.90	Upgrade
EPS (Diluted)	-1.59	-2.66	-3.99	-4.99	-2.90	Upgrade
EBIT	-3.57	-5.09	-6.31	-6.72	-3.27	Upgrade

Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q